Cite
HARVARD Citation
Efficace, F. et al. (2018). Patient‐reported outcomes enhance the survival prediction of traditional disease risk classifications: An international study in patients with myelodysplastic syndromes. Cancer. 124 (6), pp. 1251-1259. [Online].